Diagnosing coinfection in pneumonia can be challenging because of timing of the sample collection and false-negative results when the viruses replicate in the lower respiratory tract.
Researchers conducted a post hoc analysis on antipneumococcal antibody responses in patients with SLE previously immunized with the 23-valent pneumococcal polysaccharide vaccine.
Patients diagnosed with community-acquired pneumonia with higher levels of fibroblast growth factor-21 may have higher mortality rates and longer hospitalizations.
Adults hospitalized for pneumonia who received an influenza vaccination during their stay were less likely to seroconvert if they had diabetes, bacterial detection, baseline seropositive titers for influenza B, or influenza vaccination in the previous season.
Compared with those at children’s hospitals, children receiving CAP care at other hospital types are less likely to be treated as per national guidelines.
A marked and rapid reduction in PCV13 serotype, the most common antibiotic-nonsusceptible S pneumoniae, carriage was observed in both ethnic populations included in this study.
Results showed pks carriage by a causative strain was an independent risk factor for 30-day mortality in patients with K pneumoniae bloodstream infections, especially when accompanied by MDR.
A meta-analysis of case-control studies supports the use of the 13-valent pneumococcal conjugate vaccine in children as it protects against serotype 3.
Recommended indications for Streptococcus pneumoniae and Legionella pneumophila antigen testing for CAP have poor sensitivity and specificity for identifying patients to screen.
